Article

Toward a Multidimensional Formulation of Alzheimer's Disease Pathogenesis and Pathophysiology

Rodrigo O. Kuljis discusses the challenges to our understanding of neurodegenerative disorders and to the development of effective treatments and prevention presented because we lack a “satisfactory, unanimously agreed and unifying conceptual scheme” for them.

Presenter Rodrigo O. Kuljis discusses the challenges to our understanding of neurodegenerative disorders and to the development of effective treatments and prevention presented because we lack a “satisfactory, unanimously agreed and unifying conceptual scheme” for them. Dr. Kuljis’ proposes that resolving this will require researchers to address “in an integrated fashion the multiple dimensions and scales of organization of the central nervous system, that transcend the conventional boundaries of biochemistry/molecular biology, systems neuroscience, and nosology—among others—as well as going beyond the timescales usually considered in this approach.” His poster presentation offered “a more integrated conceptual scheme to tackle the complexity of neurodegenerative disorders” and offered “considerable advantages over the present, admittedly fruitful, but not yet sufficiently successful and increasingly “atomizing” analytic approach to Alzheimer’s disease and most other degenerative conditions that cause dementia.”

MP3 DOWNLOAD: RODRIGO_KULJIS.mp3

(Right click to download podcasts)

Related Videos
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.